FIXED DURATION TREATMENT OF BENDAMUSTINE‐RITUXIMAB AND ACALABRUTINIB IN FRONTLINE WALDENSTROM’S MACROGLOBULINEMIA: DEEP MOLECULAR RESPONSES IN HIGH‐RISK PATIENT SUBSETS Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Suleman, A
  • Roos, K
  • Mangoff, K
  • Jiang, Y
  • Klein, G
  • Villa, D
  • MacDonald, D
  • Aljama, Mohammed
  • Shafey, M
  • Forward, N
  • Larouche, J
  • Nikonova, A
  • Sebag, M
  • Sandhu, I
  • Chow, S
  • McClure, R
  • Gallucci, M
  • Simmons, H
  • Tomlinson, G
  • Berinstein, NL

publication date

  • June 2025